Bhavna Patel
About Bhavna Patel
Bhavna Patel is a Senior Clinical Project Manager in Clinical Operations at Deciphera Pharmaceuticals, with over 15 years of experience in the pharmaceutical and biotech industries. She has held various roles in clinical project management, specializing in trials for rare genetic diseases and oncology.
Current Role at Deciphera Pharmaceuticals
Currently, Bhavna Patel serves as a Senior Clinical Project Manager in Clinical Operations at Deciphera Pharmaceuticals. She has held this position since 2020, contributing to the management of clinical trials and ensuring adherence to timelines and budgets. Her responsibilities include overseeing the execution of clinical study reports and maintaining study site finances, which are critical for the successful completion of clinical projects.
Previous Experience at Sarepta Therapeutics
Before joining Deciphera Pharmaceuticals, Bhavna Patel worked at Sarepta Therapeutics as a Clinical Study Manager from 2018 to 2020. During her tenure in Cambridge, MA, she managed clinical studies focused on rare diseases, enhancing her expertise in the field and contributing to the advancement of therapeutic options for patients.
Experience at Takeda Pharmaceuticals
Bhavna Patel was employed at Takeda Pharmaceuticals as a Clinical Study Manager from 2015 to 2018, also in Cambridge, MA. In this role, she managed various clinical trials, further developing her skills in project management and regulatory compliance within the pharmaceutical industry.
Educational Background in Medical Biochemistry
Bhavna Patel earned her Bachelor of Science (BSc) in Medical Biochemistry from Brunel University, where she studied from 2001 to 2005. This educational foundation provided her with essential knowledge in biochemistry, which she applies in her clinical project management roles within the pharmaceutical and biotech sectors.
Expertise in Clinical Trials and Research
With over 15 years of experience in the pharmaceutical and biotech industries, Bhavna Patel specializes in managing clinical trials across all phases, including Phase I, II, III, and IV. She has a strong background in oncology, particularly in Chronic Myeloid Leukemia, and has worked on clinical trials for rare genetic diseases such as Lysosomal Deficiency Disease and Duchenne Muscular Dystrophy. Her experience includes managing Expanded Access and Compassionate Use Programs, as well as conducting healthy volunteer studies and Phase 1 First in Human studies.